-Reuters
Merrimack Pharmaceuticals Q3 EPS $(0.03) Up From $(0.04) YoY
Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $(0.03) per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year.